These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Magnetic resonance imaging tractography as a diagnostic tool in patients with spinal cord injury treated with human embryonic stem cells. Shroff G Neuroradiol J; 2017 Feb; 30(1):71-79. PubMed ID: 28058985 [TBL] [Abstract][Full Text] [Related]
4. Human embryonic stem cells. Damdimopoulou P; Rodin S; Stenfelt S; Antonsson L; Tryggvason K; Hovatta O Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():2-12. PubMed ID: 26602389 [TBL] [Abstract][Full Text] [Related]
5. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723 [TBL] [Abstract][Full Text] [Related]
6. Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury. Shin JC; Kim KN; Yoo J; Kim IS; Yun S; Lee H; Jung K; Hwang K; Kim M; Lee IS; Shin JE; Park KI Neural Plast; 2015; 2015():630932. PubMed ID: 26568892 [TBL] [Abstract][Full Text] [Related]
7. A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury. Curtis E; Martin JR; Gabel B; Sidhu N; Rzesiewicz TK; Mandeville R; Van Gorp S; Leerink M; Tadokoro T; Marsala S; Jamieson C; Marsala M; Ciacci JD Cell Stem Cell; 2018 Jun; 22(6):941-950.e6. PubMed ID: 29859175 [TBL] [Abstract][Full Text] [Related]
11. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Moviglia GA; Fernandez Viña R; Brizuela JA; Saslavsky J; Vrsalovic F; Varela G; Bastos F; Farina P; Etchegaray G; Barbieri M; Martinez G; Picasso F; Schmidt Y; Brizuela P; Gaeta CA; Costanzo H; Moviglia Brandolino MT; Merino S; Pes ME; Veloso MJ; Rugilo C; Tamer I; Shuster GS Cytotherapy; 2006; 8(3):202-9. PubMed ID: 16793729 [TBL] [Abstract][Full Text] [Related]
12. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896 [TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Liu J; Han D; Wang Z; Xue M; Zhu L; Yan H; Zheng X; Guo Z; Wang H Cytotherapy; 2013 Feb; 15(2):185-91. PubMed ID: 23321330 [TBL] [Abstract][Full Text] [Related]
15. Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy. Al-Zoubi A; Jafar E; Jamous M; Al-Twal F; Al-Bakheet S; Zalloum M; Khalifeh F; Radi SA; El-Khateeb M; Al-Zoubi Z Cell Transplant; 2014; 23 Suppl 1():S25-34. PubMed ID: 25372344 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. Shroff G; Gupta A; Barthakur JK J Transl Med; 2014 Dec; 12():318. PubMed ID: 25496119 [TBL] [Abstract][Full Text] [Related]
17. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report. Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Huang H; Xi H; Chen L; Zhang F; Liu Y Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677 [TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Kumar AA; Kumar SR; Narayanan R; Arul K; Baskaran M Exp Clin Transplant; 2009 Dec; 7(4):241-8. PubMed ID: 20353375 [TBL] [Abstract][Full Text] [Related]
20. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. Shapiro S; Borgens R; Pascuzzi R; Roos K; Groff M; Purvines S; Rodgers RB; Hagy S; Nelson P J Neurosurg Spine; 2005 Jan; 2(1):3-10. PubMed ID: 15658119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]